| Name | Title | Contact Details |
|---|
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Since 1987, Valley Behavioral Health has provided comprehensive treatment and services for people of all ages who are experiencing serious mental illness, substance use disorders and behavior problems. We believe people are best served in the least restrictive setting where care is tailored to the individual's needs. Families and community partners play an important role in a person's recovery.
At Eisenhower Health, we offer a progressive environment with an emphasis on individual growth and advanced medical practices seldom seen in other hospitals. As a not-for-profit and comprehensive health care institution located in Southern California, we are the proud recipient of the 2009 Distinguished Hospital award for Excellence™ by HealthGrades® and the 2011 Gallup Great Workplace award. Located on 130 acres in Rancho Mirage, we offer our community a 476-bed acute care hospital with telemetry, critical care and medical/surgical floors. We also have a multitude of specialty centers including The Betty Ford Center, The Barbara Sinatra Children`s Center and The Annenberg Center for Health Sciences. Eisenhower is renowned for its Centers of Excellence in Orthopedics, ranked #1 in California for Joint Replacement three years in a row (2008, 2009 & 2010) in HealthGrades®, as well as its Centers of Excellence in Cardiovascular, Neuroscience and Oncology. Additionally, Eisenhower was the first hospital in Riverside and San Bernardino counties to be designated a Certified Primary Stroke Center by The Joint Commission. Eisenhower Health was also recently voted “The Top 20 Most Beautiful Hospitals” by Soliant Health, fostering a respectful, supportive and friendly work environment.
Get relief today in the Phoenix Area! We treat whiplash, knee, back, shoulder, joint pain and more! No narcotics, no surgery, just relief!
Sigma Telemed is a York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.